Evidence map›Paper›PMID 28959351›Full record

ArticleIranian journal of biotechnology2017

Cloning, Overexpression and

Niloofar Zandvakili, Mohammadreza Zamani, Mostafa Motallebi, Zahra Moghaddassi Jahromi

Open access · bronzeAbstract read
In one paragraph

Article in Iranian journal of biotechnology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 24 citations in OpenAlex.

  1. Plants (Basel, Switzerland) · 2025
    Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Niloofar ZandvakiliDepartment of Plant Molecular Biotechnology, Institute of Agricultural Biotechnology (IAB), NIGEB, Tehran, 14965/161, Iran.
Mohammadreza ZamaniDepartment of Plant Molecular Biotechnology, Institute of Agricultural Biotechnology (IAB), NIGEB, Tehran, 14965/161, Iran.
Mostafa MotallebiDepartment of Plant Molecular Biotechnology, Institute of Agricultural Biotechnology (IAB), NIGEB, Tehran, 14965/161, Iran.
Zahra Moghaddassi JahromiDepartment of Plant Molecular Biotechnology, Institute of Agricultural Biotechnology (IAB), NIGEB, Tehran, 14965/161, Iran.
National Institute of Genetic Engineering and Biotechnology · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPlants have various defense mechanisms such as production of antimicrobial peptides, particularly pathogenesis related proteins (PR proteins). PR10 family is an essential member of this group, with antifungal, antibacterial and antiviral activities.

objectiveThe goal of this study is to assess the antifungal activity of maize PR10 against some of fungal phytopathogens. MATERIALS AND

methods

resultsRecombinant maize PR10 exerted broad spectrum antifungal activity against

conclusionsMaize PR10 has the potential to be used as the antifungal agent against diff erent fungal phytopathogens. Therefore, this protein can be used in order to produce antifungal agents and fungi resistance transgenic plants.

Indexed as

Antifungal activityBioassayPathogenesis related proteinsPR10Zea mays

Identifiers

PMID28959351
PMCPMC5582252
OpenAlexW2612639904

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.